A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classificationEstelle Verburgh, G. Verhoef, Michel Delforge et al.|Leukemia|2007Cited by 66
Additional Prognostic Value of Bone Marrow Histology in Patients Subclassified According to the International Prognostic Scoring System for Myelodysplastic SyndromesEstelle Verburgh, G. Verhoef, Ruth Achten et al.|Journal of Clinical Oncology|2003Cited by 62